NCT06715566Not yet recruiting
More Steps Towards an Active Life After Stroke - ActForStroke
More Steps Towards an Active Life - ActForStroke
Source: ClinicalTrials.gov · Last updated 4 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The main goal of this quasi-experimental study is to prevent the negative consequences of mobility impairments after stroke. These include recurrent strokes, general deconditioning, and overweight on the physical side, and dependency, isolation, caregiver strain, and reduced quality of life from a psycho-social perspective. ActForStroke, a combination of high-intensity gait training and subsequent remote coaching and activity monitoring, will contribute to more steps, higher activity levels and increased participation. ActForStroke requires minimal extra resources and can easily be implemented within existing staffing levels. The investigators want to examine if patients who participate in the ActForStroke intervention are more active one year after stroke. Patients with stroke will either participate in a combined intervention of high-intensity gait training and subsequent coaching to facilitate physical and social activity or receive standard care.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 18 Nov 2024
- Start date
- 1 Jan 2025
- Primary completion date
- 31 Jul 2026
- Lead sponsor
- University of Aarhus
- Diseases
- Stroke
- NCT number
- NCT06715566
What you commit to
- Study type: Interventional
- Planned participants: 50
- From 1 Jan 2025 to the primary completion date, 31 Jul 2026
- 10 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- any disorder that prevented walking \> 50 meters prior to injury
Other illness
- uncontrolled cardiopulmonary, metabolic, infectious or psychiatric disorders
Other
- Use of bracing or instrumentation (e.g. ventilator) that limits walking independence in walking outdoors and on stairs
- Functional Ambulation Category (FAC) at admission = 5 (independent ambulator on all surfaces)
Who the study is looking for
- ≥18 years
- stroke within the last 6 months
- able to give informed consent according to the neurorehabilitation team's evaluation and/or cognitive testing
- receiving rehabilitation for post-stroke functional impairments.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (10)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Genoptræning Aalborg Municipality Coordinator of this site? Confirm its status | Aalborg | Denmark | Unknown status |
| Neuroenhed Nord Brønderslev Coordinator of this site? Confirm its status | Brønderslev | Denmark | Unknown status |
| Neurocentet København Coordinator of this site? Confirm its status | Copenhagen | Denmark | Unknown status |
| Favrskov Municipality Coordinator of this site? Confirm its status | Hammel | Denmark | Unknown status |
| Hammel Neurocenter and University Research Clinic, Denmark Coordinator of this site? Confirm its status | Hammel | Denmark | Unknown status |
| Jammerbugt Municipality Neuroteam Coordinator of this site? Confirm its status | Jammerbugt | Denmark | Unknown status |
| Skive Sundhedsafdeling Coordinator of this site? Confirm its status | Skive | Denmark | Unknown status |
| Svendborg Neurorehabilitation Coordinator of this site? Confirm its status | Svendborg | Denmark | Unknown status |
| Thisted Municipality Coordinator of this site? Confirm its status | Thisted | Denmark | Unknown status |
| Vejle Municipality Coordinator of this site? Confirm its status | Vejle | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.